Extracorporeal Membrane Oxygenation Machine (ECMO) Market Research, 2033
The global extracorporeal membrane oxygenation machine market size was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. The increase in prevalence of conditions such as chronic obstructive pulmonary disease, heart failure, and acute respiratory distress syndrome necessitates advanced life-support technologies like extracorporeal membrane oxygenation machine thus driving the growth of the extracorporeal membrane oxygenation machine market.
An extracorporeal membrane oxygenation machine is an advanced life-support system used to provide prolonged cardiac and respiratory support to patients whose heart and lungs are unable to function on their own. The machine helps circulate the blood outside the body, removing carbon dioxide, adding oxygen, and then returning the oxygenated blood back to the patient. It is used in critical care settings across the healthcare sector.
The extracorporeal membrane oxygenation machine system consists of a pump, an oxygenator and monitoring equipment. Blood is drained from the patient through a cannula inserted into a large vein, pumped through the oxygenator where gas exchange occurs, and then returned to the body. The oxygenator contains a semi-permeable membrane that allows oxygen to enter the blood and carbon dioxide to exit, mimicking the natural function of the lungs.
Market Introduction and Definition
Patients whose hearts and lungs are unable to sustain adequate gas exchange or perfusion to preserve life can receive prolonged cardiac and respiratory support via extracorporeal membrane oxygenation. It functions by momentarily withdrawing blood from the body to enable artificial red blood cell oxygenation and carbon dioxide elimination. It provides critical support for patients with life-threatening heart and lung failure, also allows time for recovery from severe conditions and can be used as a bridge to further treatments, such as transplant.
Extracorporeal membrane oxygenation machine is not a permanent treatment but a temporary supportive therapy. It is used as a bridge for recovery. It allows the heart and lungs to heal. In some cases, it serves as a bridge to definitive treatments. Advancements in technology help improve extracorporeal membrane oxygenation machine design over time. Modern systems are compact, portable, and user-friendly compared to earlier models. Improvements in biocompatible materials reduce the risk of blood clotting and inflammation.
Key Takeaways
- The extracorporeal membrane oxygenation machine market size study covers 20 countries.
- The research includes a segment analysis of each country in terms of value ($Million) for the projected period.
- The report offer industry insights for all the stakeholders to smoothen the decision-making.
- The study integrates high-quality data, professional opinions and analysis and is intended to provide a balanced view of global markets and to assist stakeholders in making decisions to achieve their growth objectives.
Key Market Dynamics
The market for extracorporeal membrane oxygenation machines is significantly influenced by the rise in incidence of severe cardiac and respiratory conditions. The safety and efficacy of extracorporeal membrane oxygenation machines are improved by ongoing technological advancements in oxygenators, biocompatible materials, and user-friendly interfaces. These machines are widely available for usage in a variety of therapeutic contexts, such as field hospitals and patient transport, owing to advancements in portability and miniaturization.
Patent Analysis, 2015-2024
Although the ECMO machine market share growth has been more rapid in recent years, the industry can draw on the patents filed by various companies across various countries. For instance, patents filed by China dominated the same with a 45.5% share, the U.S. holds a share of about 9.1% and the Patent Cooperation Treaty (PCT) holds a share of about 20.5%.
Drivers
Increase in prevalence of cardiovascular and respiratory disorders is one of the major factors driving the growth of the extracorporeal membrane oxygenation machine market. Moreover, there is rise in prevalence of heart failure, cardiogenic shock, acute respiratory distress syndrome, and chronic obstructive pulmonary disease. Extracorporeal membrane oxygenation machine provides critical support for patients with severe cases of these conditions when conventional therapies fail.
Rise in number of cardiac and lung transplant procedures also foster the growth of the extracorporeal membrane oxygenation machine market. Extracorporeal membrane oxygenation machine is often used as a bridge to transplantation, supporting patients while they await donor organs. Improvements in transplant programs also fuel the demand for extracorporeal membrane oxygenation machine systems. Technological advancements which make way for safe, efficient, and easy to manage extracorporeal membrane oxygenation machines are opportunistic for the growth of the extracorporeal membrane oxygenation machine market. Portable extracorporeal membrane oxygenation machine units allow for patient transport between facilities, expanding clinical use beyond large tertiary hospitals.
Restraints
The high cost of extracorporeal membrane oxygenation machine and associated disposables limits adoption of these machines across the healthcare centers. In addition the machines also need highly trained personnel and continuous monitoring, which increases operational costs. This deters the growth of the market.
Opportunities
Ongoing technological innovation also makes way for lucrative growth opportunities for the extracorporeal membrane oxygenation machine market. Further, development of smaller, portable, and automated extracorporeal membrane oxygenation machine systems help reduce training requirements and broaden adoption. These factors are anticipated to foster the growth of the extracorporeal membrane oxygenation machine industry landscape during the forecast period.
What Is the Current Market Size and How Is the Market Expected to Grow?
The global extracorporeal membrane oxygenation machine market has been growing steadily as hospitals and critical care centers adopt advanced life-support technologies to manage severe respiratory and cardiac failure. According to Allied Market Research, the extracorporeal membrane oxygenation machine market was valued at $504.2 million in 2023. Extracorporeal membrane oxygenation machine systems are advanced devices used to oxygenate the blood of the patient outside the body and support heart or lung function when traditional therapies are insufficient. Their use is especially critical in cases of acute respiratory distress syndrome (ARDS), heart failure, cardiogenic shock, and other life-threatening conditions.
Looking ahead, the market is projected to grow significantly over the next decade. Allied Market Research forecasts that the market will reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. This growth reflects steady demand for extracorporeal membrane oxygenation machine across major healthcare systems in North America, Europe, and Asia-Pacific.
The increase in incidence of cardiopulmonary diseases, including chronic obstructive pulmonary disease (COPD), pneumonia, and heart failure, contributes strongly to market expansion. These conditions often lead to respiratory or circulatory failure, where extracorporeal membrane oxygenation machine serves as a crucial last-resort life-saving intervention.
Another important factor is the acceptance of extracorporeal membrane oxygenation machine therapy in critical care settings, including intensive care units (ICUs). Advances in machine design, such as improved oxygenators, portable consoles, and integrated monitoring systems, have made extracorporeal membrane oxygenation machine more effective and accessible for broader clinical use.
Regionally, North America holds the largest share of the extracorporeal membrane oxygenation machine market due to well-developed healthcare infrastructure, high adoption of advanced medical technologies, and favorable reimbursement frameworks. Asia-Pacific is emerging as one of the fastest-growing markets, supported by investments in healthcare infrastructure and rising awareness of advanced life-support systems.
Market Segmentation
The extracorporeal membrane oxygenation machine market analysis is segmented on the basis of type, component, application, and region. Based on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, the market is classified into pumps, oxygenator, controllers, and others. Based on application, the market is classified into adult, pediatric, and neonates. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America accounted for a major extracorporeal membrane oxygenation machine market size owing to the presence of several major players, availability of advanced healthcare facilities; and high healthcare infrastructure expenditure by the government organizations in the region which drive the growth of the market. Moreover, this is attributed to the rise in incidences of chronic diseases, and the strong presence of key market players in the region.
Asia-Pacific extracorporeal membrane oxygenation machine market share is estimated to grow with the highest CAGR during the forecast period, owing to enhancements in healthcare facilities, increase in prevalence of chronic diseases, surge in awareness about early disease diagnosis, and rise in healthcare expenditure. In addition, this region offers lucrative opportunities for the extracorporeal membrane oxygenation machine market key players, owing to a rise in awareness of advanced medical technologies.
How Is the Market Performing Compared to Previous Years?
The extracorporeal membrane oxygenation machine market has shown consistent growth compared to previous years, reflecting an expansion in both demand and clinical application. This growth is attributed to rise in deployment of extracorporeal membrane oxygenation machine technology in hospitals and critical care units worldwide.
Historical performance demonstrates a trend of steady growth. Providers of extracorporeal membrane oxygenation machine systems reported increased clinical usage as awareness of the benefits of extracorporeal membrane oxygenation machine therapy expanded. Hospitals and surgical centers increasingly adopted these machines to improve survival rates for patients with severe respiratory or cardiac failure, conditions that often do not respond to conventional treatments.
Regionally, North America maintained leadership in extracorporeal membrane oxygenation machine market share due to advanced healthcare infrastructure, strong reimbursement policies, and higher adoption rates of extracorporeal membrane oxygenation machine systems. Europe and Asia-Pacific also experienced increased interest, though the rate of adoption varied depending on healthcare investments and clinical practices.
Industry Trends
- Innovations leading to smaller, portable ECMO systems that can be used outside traditional ICU settings, including during patient transport and in emergency situations.
- Incorporation of digital health technologies, such as remote monitoring, data analytics, and artificial intelligence, to improve patient management and outcomes.
Competitive Landscape
The major players operating in the extracorporeal membrane oxygenation (ECMO) machine market are Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Getinge AB, Livanova Plc, and Fresnius Medical Care.
What Are the Strategies Adopted by the Key Players in the Extracorporeal Membrane Oxygenation Machine Market?
Major players such as Medtronic and Getinge AB focus heavily on securing regulatory approvals and launching upgraded extracorporeal membrane oxygenation machine systems with improved performance and usability. Strategic partnerships and regional expansion are common tactics. Some companies are establishing subsidiaries and regional sales outlets in emerging markets such as the Middle East and Asia-Pacific to broaden their reach. Collaborations between manufacturers and other healthcare companies or technology developers help drive complementary offerings and bundled solutions. These partnerships can expand clinical use cases, such as combining extracorporeal membrane oxygenation machine with adjunctive therapies, increasing the overall value of the systems to hospitals and intensive care units.
Recent Developments
- In November 2022, LivaNova PLC a market-leading medical technology and innovation company, announced it received 510 (k) clearance for extracorporeal membrane oxygenation (ECMO) from the U.S. Food and Drug Administration (FDA) for LifeSPARC, the Company’s next-generation Advanced Circulatory Support (ACS) pump and controller system.
- In July 11, 2022, Inspira Technologies OXY B.H.N. Ltd. announced the "Liby" System, an advanced form of life support the extracorporeal membrane oxygenation (ECMO) machine, used to treat patients with life-threatening heart and lung failure.
Key Sources Referred
- National Center for Biotechnology Information
- World Health Organization (WHO)
- National Library of Medicine
- The United States Food and Drug Administration
- U.S. Department of Health & Human Services
- Centers for Disease Control and Prevention
- Australian Institute of Health and Welfare
- Johns Hopkins Medicine
- National Centre for Disease Control (NCDC)
- American Heart Association, Inc.
- NHS Blood and Transplant
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the extracorporeal membrane oxygenation machine market from 2024 to 2033 to identify the prevailing extracorporeal membrane oxygenation machine market opportunities.
- The extracorporeal membrane oxygenation machine market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the ECMO machine industry players segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global extracorporeal membrane oxygenation machine market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the ECMO machine industry players.
- The report includes the analysis of the regional as well as global ECMO machine market forecast, key players, market segments, application areas, and extracorporeal membrane oxygenation machine market growth strategies.
Extracorporeal Membrane Oxygenation Machine (ECMO) Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 793.7 Million |
 Growth Rate | CAGR of 4.6% |
 Forecast period | 2024 - 2033 |
 Report Pages | 280 |
 By Type |
|
 By Components |
|
 By Application |
|
 By Region |
|
 Key Market Players | MAQUET Holding, Terumo Corporation, Nipro Medical Corporation, GETINGE AB, Medtronic Plc, Livanova Plc, Microport Scientific Corporation, Fresnius Medical Care, Medos Medizintechnik AG, Sorin Group |
Surge in the prevalence of cardiopulmonary disease is the upcoming trends of Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market
Adult is the leading application of Medical Extracorporeal Membrane Oxygenation Machine (ECMO) Market
North America is the largest regional market for Medical Extracorporeal Membrane Oxygenation Machine (ECMO)
The extracorporeal membrane oxygenation (ECMO) machine market was valued at $504.23 million in 2023 and is estimated to reach $793.60 million by 2033, exhibiting a CAGR of 4.1% from 2024 to 2033.
The major players operating in the extracorporeal membrane oxygenation (ECMO) machine market are Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, Getinge AB, Livanova Plc, and Fresnius Medical Care.
Asia-Pacific is the fastest growing regional market for Medical Extracorporeal Membrane Oxygenation Machine (ECMO)
Loading Table Of Content...
